Sumitomo Pharma America, Inc.’s Post

Sumitomo Pharma America, Inc. reposted this

View organization page for Pierre Fabre Group, graphic

379,113 followers

Pierre Fabre Laboratories are thrilled to announce that the European Commission (EC) has granted marketing authorization (MA) for their symptomatic treatment of overactive bladder syndrome in adults 🙌.   "We are delighted with this development, which will allow European patients to benefit from a new therapeutic option for overactive bladder syndrome and further strengthen our expertise of over 40 years in urology. This decision confirms Pierre Fabre Laboratories' commitment to offering patients new therapies for the management of chronic debilitating diseases." - Eric Ducournau, CEO of Pierre Fabre Laboratories.   The EC's decision follows the favorable opinion issued in April by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).  This approval is grounded in positive data from two pivotal, multicenter, double-blind, randomized phase 3 studies involving patients with overactive bladder symptoms.     At Pierre Fabre Laboratories, we are committed to pioneering advancements across diverse health fields, delivering comprehensive solutions, and prioritizing exceptional patient care 💙. 👉 Learn more on Pierre Fabre Pharmaceutical Care #PierreFabre #NewWaysToCare #Innovation #Urology HQ--07-24-2400003

  • No alternative text description for this image

Congratulations to Pierre Fabre Laboratories on this significant achievement! The approval of this new treatment for overactive bladder syndrome is a testament to your dedication and innovation in urology. 🙏🏻

Giacomo Mascherpa

Marketing Manager Dermatologia Urologia Pierre Fabre Pharma

3w

Ready to launch!!!!!

Dr. Marc Hagenhoff

Head of Medical Scientific Liaison Oncology D-A-CH

3w

Congrats, Ralf and team

Jennifer CL Woo, DVM PhD

Executive Director, Translational Medicine | Global Product Development Leader | Immunology | Biomarker Strategy | IND Enabling Pharmacology | Gene Therapy | Veterinary Pathology | Animal Models |Toxicology

3w

Congratulations to the Pierre Fabre and Urovant teams! A great joint effort!

A great accomplishment with our European partners, Pierre Fabre!

See more comments

To view or add a comment, sign in

Explore topics